SCHEMBL8198993

SCHEMBL8198993

CN1C(=O)/C(=C\c2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)SC1=S

nearest known ligand 0.69

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NAT1 P18440 1/20 0.69
▸ PTGS2 P35354 4/20 0.59
▸ MEN1 O00255 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ GAA P10253 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ HSD17B3 P37058 1/20 0.56
▸ CISD1 Q9NZ45 4/20 0.56
▸ MAOB P27338 2/20 0.56
▸ MAOA P21397 1/20 0.56
▸ PTGS1 P23219 4/20 0.54
▸ ALOX5 P09917 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7246589 1.00 NAT1 (0.69) NAT1PTGS2MEN1ALDH1A1GAA
SCHEMBL7246592 1.00 NAT1 (0.69) NAT1PTGS2MEN1ALDH1A1GAA
SCHEMBL8710470 0.86 HSD17B3 (0.70) NAT1MEN1ALDH1A1KMT2AHSD17B3
SCHEMBL8710472 0.86 HSD17B3 (0.70) NAT1MEN1ALDH1A1KMT2AHSD17B3
SCHEMBL7702501 0.85 NAT1 (0.70) NAT1PTGS2MEN1ALDH1A1GAA
SCHEMBL7702499 0.85 NAT1 (0.70) NAT1PTGS2MEN1ALDH1A1GAA
SCHEMBL8534268 0.83 PTGS2 (0.55) NAT1PTGS2MEN1ALDH1A1GAA
SCHEMBL8534273 0.83 PTGS2 (0.55) NAT1PTGS2MEN1ALDH1A1GAA
SCHEMBL6886569 0.82 NAT1 (0.53) NAT1MEN1ALDH1A1KMT2AHSD17B3
SCHEMBL8933323 0.81 PTGS2 (0.56) NAT1PTGS2MEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000032598-A9 METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES UTILIZING INHIBITORS OF TUMOR NECROSIS FACTOR ACTIVITY STRUCTURAL BIOINFORMATICS INC (US) 2000-11-30 — — WO claimed
WO-2000032598-A1 METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES UTILIZING INHIBITORS OF TUMOR NECROSIS FACTOR ACTIVITY STRUCTURAL BIOINFORMATICS INC. (US) 2000-06-08 — — WO claimed
Send feedback